Tracked deals
8
8 tracked deals across 2021-2024.
Operating Company
Healthcare
Veranex
Raleigh, North Carolina, United States
World’s first global Innovation Contract Research Organization (iCRO) providing integrated product development and contract research services for medical device and in-vitro diagnostic companies, spanning design & engineering, preclinical/clinical, regulatory, quality/manufacturing support, and market access.
- Focus Areas
- Medical device product development, Preclinical research, Clinical trials
- Website
- veranex.com
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Addon
8 addon
Veranex Acquisition Volume by Year
Last 4 years
Supporting Data
Recent Transactions
-
May 1, 2024
- Buyer
- Veranex
- Target
- HORUS Scientific
- Industry
- Healthcare Services
- Location
- Massachusetts, United States
- Type
- Addon
Veranex has acquired HORUS Scientific, a pathology and histology provider, to deepen its preclinical pathology and histology capabilities and expand its North American service footprint. The acquisition adds specialized GLP-capable histopathology services to Veranex’s integrated medtech service platform and complements its existing Paris pathology capabilities.
-
December 13, 2023
- Buyer
- Veranex
- Target
- T3 Labs
- Industry
- Medical Devices
- Location
- Georgia, United States
- Type
- Addon
Veranex has acquired T3 Labs, a preclinical laboratory based in Atlanta, Georgia. The acquisition expands Veranex's preclinical footprint in North America and deepens its medical‑device testing and therapeutic expertise to provide more integrated services to medtech clients.
-
December 13, 2022
- Buyer
- Veranex
- Target
- Fusion Biotec
- Industry
- Medical Devices
- Location
- California, United States
- Type
- Addon
Veranex has acquired Fusion Biotec, a Southern California design and engineering firm specializing in complex electro-mechanical diagnostic instrumentation and medical devices. The acquisition brings Fusion's 15,000-square-foot facility and 45+ engineering staff into Veranex's Product Design & Engineering capabilities, expanding Veranex's diagnostic/IVD development, software/firmware reuse and Southern California footprint; financial terms were not disclosed.
-
October 11, 2022
- Buyer
- Veranex
- Target
- Devicia, Clarvin, Kickfile, Lea Reg, Limulus Bio
- Industry
- Healthcare Services
- Location
- Sweden
- Type
- Addon
Veranex, a global tech-enabled medtech service provider, acquired an ecosystem of Swedish medical device and IVD consultancies led by Devicia and Clarvin (including affiliates Kickfile, Lea Reg, and Limulus Bio). The add-on expands Veranex's regulatory, clinical, quality assurance, and biocompatibility capabilities and strengthens its European and UK presence to support MDR/IVDR strategies and local representation.
-
September 20, 2022
- Buyer
- Veranex
- Target
- Medidee
- Industry
- Healthcare Services
- Location
- Vaud, Switzerland
- Type
- Addon
Veranex has acquired Medidee, a Lausanne-based MedTech regulatory and clinical consultancy, expanding Veranex's footprint and capabilities across Europe, India and APAC. The deal strengthens Veranex’s regulatory affairs, clinical development, and quality assurance services for medical device and in vitro diagnostic clients; financial terms were not disclosed.
-
December 7, 2021
- Buyer
- Veranex
- Target
- Worrell
- Industry
- Medical Devices
- Location
- Minnesota, United States
- Type
- Addon
Veranex, a global tech-enabled product development services provider backed by Summit Partners, has acquired Worrell, a 46-year-old human-centered design firm focused on healthcare innovation. The acquisition expands Veranex's human-centered design and human factors capabilities and broadens its geographic footprint with Worrell's offices in Minneapolis, Providence, the San Francisco Bay Area, London, and Shanghai.
-
October 12, 2021
- Buyer
- Veranex, Summit Partners
- Target
- IMMR
- Industry
- Medical Devices
- Location
- France
- Type
- Addon
Veranex, a global concept-to-commercialization service provider for the MedTech industry, has acquired IMMR, a Paris-based preclinical science organization providing GLP-compliant preclinical research, pathology evaluation and surgical training. The acquisition expands Veranex's preclinical capabilities with IMMR's FDA-inspected and AAALAC-accredited facilities and expert surgical teams; financial terms were not disclosed.
-
June 16, 2021
- Buyer
- Veranex, Summit Partners
- Target
- Ximedica, Quartesian, Boston Healthcare Associates
- Industry
- Healthcare Services
- Location
- United States
- Type
- Addon
Veranex, formed in partnership with growth investor Summit Partners, launched a concept-to-commercialization medtech services platform and acquired three complementary companies: Ximedica, Quartesian, and Boston Healthcare Associates. The combined business brings design and engineering, clinical data, regulatory, and market-access/HEOR capabilities together to create an integrated, global medtech service provider.
Related Acquisition Pages
Healthcare Services Buyers & Acquisitions
4 tracked deals by Veranex.
Medical Devices Buyers & Acquisitions
4 tracked deals by Veranex.
Acquisitions in California
1 tracked deal by Veranex.
Acquisitions in Georgia
1 tracked deal by Veranex.
Acquisitions in Massachusetts
1 tracked deal by Veranex.
Acquisitions in Minnesota
1 tracked deal by Veranex.
Selling a company? Get in front of buyers like Veranex
Turn tracked acquisition activity into an outreach-ready buyer list.